Blood storage conditions, age, and other factors can influence the levels of NfL, a nerve damage biomarker used in MS ...

Columnist Ben Hofmeister isn't as worried about his children inheriting MS as he is about them seeing the reality of living with the disease.

Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Vaccination didn't increase the risk of children or adolescents being diagnosed with pediatric MS within five years, a study ...

Tiziana's Phase 2 trial testing foralumab for nonactive secondary progressive multiple sclerosis (SPMS) has added six U.S.

Nabiximols and other cannabis-based treatments were seen to work well at controlling spasticity, though responses vary among ...